Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes QTLs Strains Markers Genome Information Ontologies Cell Lines References FTP Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) RatMine GViewer (Genome Viewer) Overgo Probe Designer ACP Haplotyper Genome Scanner
Aging & Age-Related Disease Cancer Cardiovascular Disease COVID-19 Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models PhenoMiner (Quantitative Phenotypes) Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Poster Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources

ONTOLOGY REPORT - ANNOTATIONS
Term:acenocoumarol
go back to main search page
Accession:CHEBI:53766 term browser browse the term
Definition:A hydroxycoumarin that is warfarin in which the hydrogen at position 4 of the phenyl substituent is replaced by a nitro group.
Synonyms:related_synonym: 3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin;   3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin;   3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin;   3-(alpha-Acetonyl-p-nitrobenzyl)-4-hydroxycoumarin;   3-(alpha-p-Nitrophenyl-beta-acetylethyl)-4-hydroxycoumarin;   4-Hydroxy-3-(1-(4-nitrophenyl)-3-oxobutyl)-2H-1-benzopyran-2-one;   4-Hydroxy-3-[1-(4-nitrophenyl)-3-oxobutyl]-2H-chromen-2-one;   Acenocoumarin;   Acenocumarolo;   Acenokumarin;   Formula=C19H15NO6;   InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3;   InChIKey=VABCILAOYCMVPS-UHFFFAOYSA-N;   Nicoumalone;   Nicumalon;   Nitrophenylacetylethyl-4-hydroxycoumarine;   Nitrovarfarian;   Nitrowarfarin;   SMILES=CC(=O)CC(c1ccc(cc1)[N+]([O-])=O)c1c(O)c2ccccc2oc1=O;   acenocoumarolum;   acenocumarol
 alt_id: CHEBI:494206
 xref: Beilstein:1269370;   CAS:152-72-7;   DrugBank:DB01418;   KEGG:D07064;   LINCS:LSM-5112
 xref_mesh: MESH:D000074
 xref: PMID:17275317;   Patent:US2648682;   Reaxys:1269370

show annotations for term's descendants       view all columns           Sort by:
 
acenocoumarol term browser
Symbol Object Name JBrowse Chr Start Stop Reference
G Abcb1a ATP binding cassette subfamily B member 1A JBrowse link 4 22,339,829 22,517,642 RGD:6480464
G Apoe apolipoprotein E JBrowse link 1 80,612,894 80,616,820 RGD:6480464
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 JBrowse link 8 62,472,087 62,478,122 RGD:6480464
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 JBrowse link 8 62,451,360 62,458,244 RGD:6480464
G Cyp2c24 cytochrome P450, family 2, subfamily c, polypeptide 24 JBrowse link 1 258,074,797 258,139,176 RGD:6480464
G Cyp2c6v1 cytochrome P450, family 2, subfamily C, polypeptide 6, variant 1 JBrowse link 1 147,713,879 147,814,410 RGD:6480464
G F10 coagulation factor X JBrowse link 16 81,803,169 81,822,476 RGD:6480464
G F2 coagulation factor II JBrowse link 3 80,529,468 80,542,993 RGD:6480464
G F5 coagulation factor V JBrowse link 13 82,479,997 82,535,540 RGD:6480464
G F7 coagulation factor VII JBrowse link 16 81,824,610 81,834,923 RGD:6480464
G F9 coagulation factor IX JBrowse link X 143,097,507 143,141,791 RGD:6480464
G Ggcx gamma-glutamyl carboxylase JBrowse link 4 100,277,345 100,293,097 RGD:6480464
G Vkorc1 vitamin K epoxide reductase complex, subunit 1 JBrowse link 1 199,338,785 199,341,306 RGD:6480464
G Vkorc1l1 vitamin K epoxide reductase complex, subunit 1-like 1 JBrowse link 12 30,218,825 30,268,990 RGD:6480464
Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19790
    chemical entity 19789
      group 19698
        inorganic group 19161
          nitro group 7279
            nitro compound 7279
              C-nitro compound 6883
                acenocoumarol 14
                  (R)-acenocoumarol 0
                  (S)-acenocoumarol 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19790
    subatomic particle 19788
      composite particle 19788
        hadron 19788
          baryon 19788
            nucleon 19788
              atomic nucleus 19788
                atom 19788
                  main group element atom 19674
                    p-block element atom 19674
                      carbon group element atom 19572
                        carbon atom 19561
                          organic molecular entity 19561
                            organic molecule 19483
                              organic cyclic compound 19246
                                organic heterocyclic compound 18366
                                  oxacycle 17135
                                    benzopyran 9489
                                      1-benzopyran 9185
                                        chromenes 923
                                          chromenone 841
                                            coumarins 561
                                              hydroxycoumarin 299
                                                acenocoumarol 14
                                                  (R)-acenocoumarol 0
                                                  (S)-acenocoumarol 0
paths to the root

Contact Us |  About Us |  License CC BY 4.0 |  Legal Disclaimer |  © Medical College of Wisconsin
NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.